Drug Type Stem cell therapy |
Synonyms Kidney specific amniotic mesenchymal stem cell therapy (Amniotics) |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerulonephritis, Membranous | Phase 2 | Sweden | - | |
| Acute Kidney Injury | Discovery | Sweden | 30 Apr 2024 | |
| Graft Rejection | Discovery | Sweden | 30 Apr 2024 |





